Clinical manifestations of CDG-Ia due to the R141H/F119L PMM2 genotype
Manifestations | No./total tested | % |
Gastrointestinal symptoms | ||
Feeding difficulties | 23/23 | 100 |
Vomiting | 19/23 | 83 |
Diarrhoea | 12/23 | 52 |
Nasogastric tube/gastrostomy | 11/23 | 48 |
Neurological manifestations | ||
Cerebellar atrophy | 18/20 | 90 |
Afebrile seizures | 13/23 | 57 |
Febrile seizures | 21/23 | 91 |
Stroke like episode | 12/23 | 52 |
Hypotonia | 23/23 | 100 |
Ataxia | 23/23 | 100 |
Peripheral muscular atrophy | 23/23 | 100 |
Psychomotor retardation | 23/23 | 100 |
Absent tendon reflexes | 23/23 | 100 |
Neurogenic hearing impairment | 3/9 | 33 |
Hepatic dysfunction | ||
Enlarged liver | 11/23 | 48 |
Increased transaminases | 23/23 | 100 |
Coagulation abnormalities | 23/23 | 100 |
Episode of bleeding | 8/23 | 35 |
Episode of ascites | 6/23 | 26 |
Episode of thromboemboli | 1/23 | 6 |
Cardiac involvement | ||
Pericardial effusion | 10/19 | 52 |
Dysmorphic features | ||
Inverted nipples | 23/23 | 100 |
Abnormal fat distribution | 21/23 | 91 |
Congenital joint restriction | 12/23 | 53 |
Hernia/hydrocele/retentio testis | 10/12 boys | 83 |
Esotropia | 23/23 | 100 |
Skeletal abnormalities | ||
Kyphoscoliosis | 11/23 | 48 |
Thorax deformity | 20/23 | 87 |
Fracture due to minimal trauma | 6/23 | 26 |